番茄社区

New antibody indicated for previously treated, unresectable or metastatic HER2-positive disease

Liver fat reductions were sustained for up to a year with the thyroid hormone receptor agonist

First positive phase III study for a GLP-1 agonist in chronic liver disease

Notably, tapering reduced the risk of infection compared with a fixed dose

A greater proportion of women on the waitlist and undergoing transplant since adoption

78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors

Improved markers of disease severity as well in small trial of steroid-ineligible patients

Targeted preventive strategies needed, especially for younger women, researchers say

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations

Agency's decision on obeticholic acid in PBC follows negative advisory committee meeting

Rifaximin also reduced mortality, but its high cost may be a barrier

Easy to apply, uses parameters commonly measured in outpatient and inpatient settings

Also in TTHealthWatch: HIV-positive kidney donors

Fatty acid synthase inhibitor targets main drivers of liver injury